Savaria (TSE:SIS – Get Free Report) had its price objective upped by Raymond James Financial from C$27.00 to C$32.00 in a research note issued to investors on Friday,BayStreet.CA reports. The firm presently has an “outperform” rating on the stock. Raymond James Financial’s target price suggests a potential upside of 23.31% from the company’s current price.
A number of other research analysts also recently issued reports on the company. TD Securities lifted their price target on Savaria from C$27.00 to C$31.00 and gave the company a “buy” rating in a report on Thursday. National Bank Financial lifted their target price on Savaria from C$30.00 to C$30.50 and gave the company an “outperform” rating in a research note on Friday. Desjardins increased their price target on shares of Savaria from C$27.00 to C$32.00 and gave the company a “buy” rating in a research report on Friday. Scotiabank lifted their price objective on shares of Savaria from C$25.00 to C$26.00 in a research report on Monday, November 10th. Finally, Stifel Nicolaus increased their target price on shares of Savaria from C$28.00 to C$29.00 and gave the company a “buy” rating in a research report on Friday. Seven investment analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the company presently has an average rating of “Buy” and a consensus target price of C$30.93.
Get Our Latest Stock Analysis on Savaria
Savaria Stock Down 1.7%
Savaria (TSE:SIS – Get Free Report) last released its quarterly earnings data on Wednesday, March 4th. The company reported C$0.37 earnings per share (EPS) for the quarter. The firm had revenue of C$241.78 million for the quarter. Savaria had a net margin of 6.90% and a return on equity of 10.24%. On average, equities analysts predict that Savaria will post 1.2048518 earnings per share for the current fiscal year.
Savaria Company Profile
Savaria Corporation ( savaria.com ) is a global leader in the accessibility industry. It provides accessibility solutions for the physically challenged to increase their comfort, their mobility and their independence. Its product line is one of the most comprehensive on the market. Savaria designs, manufactures, distributes and installs accessibility equipment, such as stairlifts for straight and curved stairs, vertical and inclined wheelchair lifts and elevators for home and commercial use. It also manufactures and markets a comprehensive selection of pressure management products for the medical market, medical beds for the long-term care market, as well as an extensive line of medical equipment and solutions for the safe handling of patients, including ceiling lifts and slings.
Featured Stories
- Five stocks we like better than Savaria
- MAJOR BUY ALERT: Mar-a-Lago/Trump/Elon
- How JPMorgan’s $8,000 Gold Call Will Leave Most Retirement Accounts Behind
- BNZI stands out as a Zacks Buy. Earnings momentum and analyst upgrades align
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- Trump’s NEW Executive Order – BIG Changes Coming to Retirement Accounts
Receive News & Ratings for Savaria Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Savaria and related companies with MarketBeat.com's FREE daily email newsletter.
